The Metabolic Syndrome

Pharmacology and Clinical Aspects

  • Henning Beck-Nielsen

Table of contents

  1. Front Matter
    Pages i-xi
  2. Knut Borch-Johnsen
    Pages 7-16
  3. John J. Nolan, Donal J. O’Gorman
    Pages 17-42
  4. Frank Pistrosch, Frank Schaper, Markolf Hanefeld
    Pages 43-54
  5. Frank Pistrosch, Markolf Hanefeld
    Pages 55-61
  6. Pirjo Ilanne-Parikka, Jaakko Tuomilehto
    Pages 63-85
  7. Marc-Andre Cornier, Boris Draznin
    Pages 87-98
  8. Clifford J. Bailey
    Pages 99-116
  9. Seda Suvag, Kristina M. Utzschneider, Steven E. Kahn
    Pages 117-146
  10. Peter M. Nilsson
    Pages 147-153
  11. Tina Vilsbøll, Salvatore Calanna, Filip K. Knop
    Pages 165-183
  12. Michael Hecht Olsen
    Pages 185-190
  13. Back Matter
    Pages 227-229

About this book

Introduction

Metabolic syndrome is a common syndrome affecting about 20% of the adult population in Europe, and the prevalence is likely similar in other industrialised countries worldwide. It is mainly caused by the western lifestyle, which tends to produce abdominal obesity, but a genetic predisposition also plays a part. This syndrome, which is linked to leisure lifestyles and overeating/obesity, can develop into type 2 diabetes, cardiovascular disease and cancer. Therefore, proper treatment and prevention are essential. This book discusses lifestyle intervention and treatment, specifically with pharmacological compounds, in order to formulate a strategy for treating the metabolic syndrome in daily practice.

Keywords

abdominal obesity epidemiology metabolic syndrome pharmacology

Editors and affiliations

  • Henning Beck-Nielsen
    • 1
  1. 1.Dept. EndocrinologyOdense University HospitalOdense CDenmark

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-7091-1331-8
  • Copyright Information Springer-Verlag Wien 2013
  • Publisher Name Springer, Vienna
  • eBook Packages Medicine
  • Print ISBN 978-3-7091-1330-1
  • Online ISBN 978-3-7091-1331-8
  • About this book